FDA's predetermined change control plan (PCCP) may play a growing role for AI devices
Industry summaries say the FDA's PCCP tool can speed up updates to AI-based devices by specifying in advance which modifications are authorized. According to a legal analysis, the FDA may give greater weight in premarket review to a plan that anticipates how the device may learn and change.
Who is affected and how
- medtech company
- Scheduled, pre-approved frameworks for model updates should already be planned at the time of submission.
- health IT
- Vendors should be asked for the change limits set out in their PCCP, so it is clear what can be updated without separate authorization.
Sources
- AI in medical devices: What the FDA's predetermined change control plan actually coverscegeka.com · Aug 17, 2026
- FDA weighs new oversight model for AI medical devicesbeckershospitalreview.com · Aug 18, 2026
- FDA Seeks Public Input on AI Medical Devices That Can Change Their Answersmedical daily · Aug 19, 2026
- FDA Seeks Input on GenAI-Enabled Medical Device Regulationexecutivegov · Aug 19, 2026
- FDA seeks input on regulatory framework for generative AI-enabled medical devicesallsci · Aug 19, 2026
- FDA Seeks Public Input on Regulatory Framework for Generative AI-Enabled Medical Devicesapplied clinical trials online · Aug 19, 2026
- FDA Seeks Public Feedback on Regulation of Generative AI-Enabled Medical Devicesoncodaily · Aug 19, 2026
- FDA Opens Public Comment on Generative AI Medical Device Rules, Deadline October 19techjacksolutions.com · Aug 19, 2026
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.